Skip to main content
OpenTrials
Completed

NCT Number: NCT00155675

Pseudodrynaria Coronana (Wall) Ching

The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 1

Primary location

National Taiwan University Medical Center

Taipei, 7, Chung-Shan S. Road, 100, Taiwan

About this study

Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postmenpausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal woman with established osteoporosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • postmenopausal osteoporosis

Exclusion criteria

  • Insulin dependent diabetes

Treatment and study plan

GUSUIBU

Drug

Primary outcomes

  1. one year

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Collaborators

  • Sheng Chang Pharmaceutical

Registry information

Official study title

Clinical Effect of Traditional Chinese Medicine - "Gusuibu"

Important dates

Study start
2000
Study completion
2001
First posted
Sep 12, 2005
Registry last updated
Jan 12, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.